RDTCF - Rapid Dose Therapeutics GAAP EPS of -C$0.01 revenue of C$61.77K February, 01 2023 04:53 PM Rapid Dose Therapeutics Corp Rapid Dose Therapeutics press release ( OTCPK:RDTCF ): Q3 GAAP EPS of -C$0.01. Revenue of C$61.77K (-92.5% Y/Y). For further details see: Rapid Dose Therapeutics GAAP EPS of -C$0.01, revenue of C$61.77K